Literature DB >> 14716436

[Surgery of benign liver tumors: indications for treatment. Personal experience and review of the literature].

András Petri1, József Höhn, Antal Wolfárd, Erzsébet László Kókai, Gábor Kocsis Savanya, Mihály Boros, Adám Balogh.   

Abstract

BACKGROUND AND AIMS: Our aim is to give an audit of our experience over the past two decades in the form of a retrospective study. PATIENTS/
METHODS: Between 1 January, 1982 and 15 December, 2001, 133 patients with benign liver tumor (adenoma: 22, focal nodular hyperplasia: 27, hemangioma: 83, lipoma: 1) were treated. A total of 113 patients underwent surgery, while 20 asymptomatic cases were merely observed. The mean age, the female/male ratio and the size of the tumor in the adenoma cases were 38.3+/-10.2 years, 20/2 and 7.7+/-2.4 cm, while for focal nodular hyperplasia they were 39.5+/-12.4, 24/3 and 6.3+/-2.7 cm, and for hemangioma 49.01+/-10.7, 62/21 and 6.5+/-3.6 cm. The results were compared and analyzed statistically.
RESULTS: Enucleation was performed in 53.1% of the patients, non-anatomical resection in 24.8%, segmentectomy in 6.2%, lobectomy in 4.4%, extended lobectomy in 1.8%, stitching in 5.3%, exploration in 3.5% and liver transplantation in 0.9%. The overall 30-day postoperative mortality was 0.9% (1/113). Minor or major complications occurred in a total of 27.4%.
CONCLUSIONS: Patients with asymptomatic focal nodular hyperplasia or hemangiomas must be excluded from surgery. Surgery is indicated only when growth or severe complaints are observed. Adenomas must be resected because of the precancerous behavior and the danger of bleeding from a rupture.

Entities:  

Mesh:

Year:  2004        PMID: 14716436     DOI: HUON.2003.47.4.0391

Source DB:  PubMed          Journal:  Magy Onkol        ISSN: 0025-0244


  1 in total

1.  "Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma.

Authors:  Denis Ehrl; Katharina Rothaug; Peter Herzog; Bernhard Hofer; Horst-Günter Rau
Journal:  HPB Surg       Date:  2012-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.